News for Aegerion Pharmaceuticals, Inc. - Google Finance

Is Aegerion Pharmaceuticals, Inc. (AEGR) Now a Sell?

Mon, 20 May 2013 13:42:01 GMT

Is Aegerion Pharmaceuticals, Inc. (AEGR) Now a Sell?
Insider Monkey (blog) - 7 hours ago

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) had previously reported that patient cost would be between $200,000 and $300,000 annually for Juxtapid.

Aegerion Pharmaceuticals Given a $77.00 Price Target by Lazard Capital ... - The Utah People's Post

Aegerion Pharmaceuticls Inc.a (NASDAQ:AEGR)'s shares down by 1.56%

Fri, 17 May 2013 14:54:44 GMT

Aegerion Pharmaceuticls Inc.a (NASDAQ:AEGR)'s shares down by 1.56%
USMarketsDaily - May 17, 2013

Northern, WI 05/17/2013 (usmarketsdaily) - The prices of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) currently trading at $60.74, down by 1.56%.

Aegerion Pharmaceuticals, Inc. (AEGR) Tops Q1 EPS by 7c

Tue, 30 Apr 2013 11:35:19 GMT

Aegerion Pharmaceuticals, Inc. (AEGR) Tops Q1 EPS by 7c
StreetInsider.com (subscription) - Apr 30, 2013

Aegerion continues to expect total operating expenses, excluding stock-based compensation expense, to be between $75 and $85 million in 2013.

Aegerion Pharmaceuticals Management Discusses Q1 2013 Results - Earnings ... - Seeking Alpha
Wall Street Gets It Backward On Amgen Cholesterol Drug - Forbes

Mid-Day Market Movers: Aegerion Pharmaceuticals, Inc., Cisco Systems, Inc ...

Thu, 16 May 2013 18:46:35 GMT

Mid-Day Market Movers: Aegerion Pharmaceuticals, Inc., Cisco Systems, Inc ...
SBWire (press release) - May 16, 2013

Huntington Beach, CA -- (SBWIRE) -- 05/16/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks traded on the NASDAQ, ...

AEGERION PHARMACEUTICALS INC. : Anne VanLent Appointed to Aegerion ...

Mon, 29 Apr 2013 11:47:40 GMT

AEGERION PHARMACEUTICALS INC. : Anne VanLent Appointed to Aegerion ...
4-traders (press release) - Apr 29, 2013

CAMBRIDGE, Mass., April 29, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, ...

Aegerion Pharmaceuticals Announces Presentation at the Needham Healthcare ...

Thu, 25 Apr 2013 20:08:14 GMT

Aegerion Pharmaceuticals Announces Presentation at the Needham Healthcare ...
GlobeNewswire (press release) - Apr 25, 2013

CAMBRIDGE, Mass., April 25, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often ...

Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?

Sat, 27 Apr 2013 13:04:42 GMT

Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?
Wall St. Cheat Sheet - Apr 27, 2013

Aegerion Pharmaceuticals (NASDAQ:AEGR) will report earnings before markets open on Tuesday, April 30th. Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and ...

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

Fri, 03 May 2013 20:10:49 GMT

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Wall Street Journal (press release) - May 3, 2013

CAMBRIDGE, Mass., May 3, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating ...

Aegerion Pharmaceuticals PT Raised to $85.00 at Deutsche Bank (AEGR)

Thu, 16 May 2013 20:09:35 GMT

Aegerion Pharmaceuticals PT Raised to $85.00 at Deutsche Bank (AEGR)
Mideast Time - May 16, 2013

Analysts at Jefferies Group raised their price target on shares of Aegerion Pharmaceuticals from $46.00 to $50.00 in a research note to investors on Friday, May 10th.

Aegerion Pharmaceuticals Price Target Raised to $50.00 at Jefferies Group ...

Tue, 14 May 2013 21:30:30 GMT

Aegerion Pharmaceuticals Price Target Raised to $50.00 at Jefferies Group ...
Mideast Time - May 14, 2013

Analysts at Needham & Company raised their price target on shares of Aegerion Pharmaceuticals from $36.00 to $50.00 in a research note to investors on Thursday, May 2nd.

Large Spread Trades in AEGR - The Options Insider
How one bull is staying in Aegerion - optionMONSTER Research